Forecasts data is unavailable for this security.
Consensus recommendation
- 20-Feb-25
- 20-Nov-25
- 18-Dec-25
- 15-Jan-26
- 05-Feb-26
Select bar for recommendation details.
| Recommendations | 05-Feb-26 | |
|---|---|---|
| Buy | 5 | |
| Outperform | 6 | |
| Hold | 1 | |
| Sell | 1 | |
| Strong Sell | 0 |
Share price forecast in USD
The 11 analysts offering 12 month price targets for Hikma Pharmaceuticals Plc have a median target of 2,366.02, with a high estimate of 2,656.90 and a low estimate of 1,604.28. The median estimate represents a 53.64% increase from the last price of 1,540.00.
| High | 72.5% | 2,656.90 |
| Med | 53.6% | 2,366.02 |
| Low | 4.2% | 1,604.28 |
Dividends in USD
In 2024, Hikma Pharmaceuticals PLC reported a dividend of 0.77 USD, which represents a 5.95% increase over last year. The 12 analysts covering the company expect dividends of 0.83 USD for the upcoming fiscal year, an increase of 7.27%.
Note: The percentage change is calculated using unrounded (raw) dividend values.
| Div growth (TTM) | 5.95% |
|---|
More ▼
Earnings history & estimates in USD
| Average growth rate | +7.23% |
More ▼
Revenue history & estimates in USD
| Average growth rate | +7.66% |
More ▼
